Uxin Ltd: research and development expense
Research and development expense for Uxin Ltd. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Uxin Ltd financial histories
What this measure means
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
Exact concept: us-gaap:ResearchAndDevelopmentExpense. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2016-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.
Coverage by original unit
- CNY: 2016-01-01 to 2025-12-31.
- USD: 2018-01-01 to 2025-12-31.
These are separate reported series. A newer period in one unit does not update another unit’s history or establish a currency conversion.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 12,409,000 | CNY | 2026-04-30 | 20-F · 0001493152-26-020425 |
| 2023-04-01 | 2024-03-31 | 33,820,000 | CNY | 2026-04-30 | 20-F · 0001493152-26-020425 |
| 2022-04-01 | 2023-03-31 | 37,704,000 | CNY | 2025-04-30 | 20-F · 0001641172-25-006780 |
| 2021-04-01 | 2022-03-31 | 36,200,000 | CNY | 2024-07-31 | 20-F · 0001493152-24-029702 |
| 2020-04-01 | 2021-03-31 | 74,137,000 | CNY | 2023-08-14 | 20-F · 0000950170-23-042446 |
| 2019-01-01 | 2019-12-31 | 140,006,000 | CNY | 2022-08-01 | 20-F · 0000950170-22-013561 |
| 2018-01-01 | 2018-12-31 | 124,513,000 | CNY | 2021-07-30 | 20-F · 0001104659-21-098224 |
| 2017-01-01 | 2017-12-31 | 226,010,000 | CNY | 2019-04-29 | 20-F · 0001104659-19-024306 |
| 2016-01-01 | 2016-12-31 | 167,791,000 | CNY | 2019-04-29 | 20-F · 0001104659-19-024306 |
| 2025-01-01 | 2025-12-31 | 1,774,000 | USD | 2026-04-30 | 20-F · 0001493152-26-020425 |
| 2023-04-01 | 2024-03-31 | 4,684,000 | USD | 2024-07-31 | 20-F · 0001493152-24-029702 |
| 2022-04-01 | 2023-03-31 | 5,490,000 | USD | 2023-08-14 | 20-F · 0000950170-23-042446 |
| 2021-04-01 | 2022-03-31 | 5,710,000 | USD | 2022-08-01 | 20-F · 0000950170-22-013561 |
| 2020-04-01 | 2021-03-31 | 11,316,000 | USD | 2021-07-30 | 20-F · 0001104659-21-098224 |
| 2019-01-01 | 2019-12-31 | 20,069,000 | USD | 2020-05-12 | 20-F · 0001104659-20-060191 |
| 2018-01-01 | 2018-12-31 | 47,999,000 | USD | 2019-04-29 | 20-F · 0001104659-19-024306 |
Related financial histories
- Uxin Ltd: total assets
- Uxin Ltd: total liabilities
- Uxin Ltd: stockholders equity
- Uxin Ltd: cash and cash equivalents
- Uxin Ltd: net income or loss
- Uxin Ltd: operating cash flow
- Uxin Ltd: capital expenditure payments
- Uxin Ltd: contract revenue excluding tax
- Uxin Ltd: financing cash flow
- Uxin Ltd: investing cash flow
- Uxin Ltd: retained earnings or deficit
- Uxin Ltd: basic weighted-average shares
- Uxin Ltd: diluted weighted-average shares
- Uxin Ltd: basic earnings per share
- Uxin Ltd: diluted earnings per share
- Uxin Ltd: income tax expense or benefit
- Uxin Ltd: net property, plant and equipment
- Uxin Ltd: share-based compensation expense
- Uxin Ltd: operating income or loss
- Uxin Ltd: current assets
- Uxin Ltd: interest expense
- Uxin Ltd: current liabilities
- Uxin Ltd: current accounts payable
- Uxin Ltd: goodwill carrying amount
- Uxin Ltd: net finite-lived intangible assets
- Uxin Ltd: net current accounts receivable
- Uxin Ltd: operating expenses
- Uxin Ltd: net inventory
- Uxin Ltd: gross profit
- Uxin Ltd: cost of revenue
Inspect the source
- Entity
- Uxin Ltd / CIK 0001729173
- Captured
- 2026-09-21T17:27:44.387Z
- SEC response SHA-256
d1ff50b1a8d4f364a7fec5b50ea62a6c577cdbf887279647aef28d1392268f83
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001729173.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))